Funding will strengthen Qkine's executive leadership team, expand its presence in the US market, accelerate research and development, scale GMP and cell therapy-grade manufacturing capabilities, and enhance its digital platforms.
Qkine to be a global distributor of Media City Scientific’s FRS™ Pioneer, a chemically-defined, animal replacement solution to support routine cell culture in traditional basal media.
Qkine will collaborate with fellow pioneers to establish the manufacturing standards and standardized frameworks necessary to accelerate the adoption of organoid technologies in drug discovery and clinical research.